Cargando…

Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression

SIMPLE SUMMARY: Cancer immunotherapy mainly targets immune system components, such as immune-suppressive networks generated by cancer cells in the tumor microenvironment (TME). Programmed cell death ligand 1, which is a secretory immune-suppressive factor, is released by tumor-associated macrophages...

Descripción completa

Detalles Bibliográficos
Autores principales: Karger, Annika, Nandigama, Rajender, Stenzinger, Albrecht, Grimminger, Friedrich, Pullamsetti, Soni Savai, Seeger, Werner, Savai, Rajkumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392679/
https://www.ncbi.nlm.nih.gov/pubmed/34439281
http://dx.doi.org/10.3390/cancers13164127
_version_ 1783743559915012096
author Karger, Annika
Nandigama, Rajender
Stenzinger, Albrecht
Grimminger, Friedrich
Pullamsetti, Soni Savai
Seeger, Werner
Savai, Rajkumar
author_facet Karger, Annika
Nandigama, Rajender
Stenzinger, Albrecht
Grimminger, Friedrich
Pullamsetti, Soni Savai
Seeger, Werner
Savai, Rajkumar
author_sort Karger, Annika
collection PubMed
description SIMPLE SUMMARY: Cancer immunotherapy mainly targets immune system components, such as immune-suppressive networks generated by cancer cells in the tumor microenvironment (TME). Programmed cell death ligand 1, which is a secretory immune-suppressive factor, is released by tumor-associated macrophages (TAMs). The TME also disrupts production of tumor-specific T cells and generates immunosuppressive leukocytes, regulatory T cells, and myeloid-derived suppressor cells. Immune checkpoint inhibitors are effective in various cancers but only in a subset of patients. Non-coding RNAs, such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are dysregulated in cancer through transcriptional, post-transcriptional, and epigenetic changes and have significant roles in cancer initiation and progression, which depends on deregulation of lncRNA expression. TAM function can be influenced by lncRNAs in various ways. However, our understanding of lncRNA dysregulation and function in cancer remains in the early stage. ABSTRACT: Ever since RNA sequencing of whole genomes and transcriptomes became available, numerous RNA transcripts without having the classic function of encoding proteins have been discovered. Long non-coding RNAs (lncRNAs) with a length greater than 200 nucleotides were considered as “junk” in the beginning, but it has increasingly become clear that lncRNAs have crucial roles in regulating a variety of cellular mechanisms and are often deregulated in several diseases, such as cancer. Lung cancer is the leading cause of cancer-related deaths and has a survival rate of less than 10%. Immune cells infiltrating the tumor microenvironment (TME) have been shown to have a great effect on tumor development with macrophages being the major cell type within the TME. Macrophages can inherit an inflammatory M1 or an anti-inflammatory M2 phenotype. Tumor-associated macrophages, which are predominantly polarized to M2, favor tumor growth, angiogenesis, and metastasis. In this review, we aimed to describe the complex roles and functions of lncRNAs in macrophages and their influence on lung cancer development and progression through the TME.
format Online
Article
Text
id pubmed-8392679
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83926792021-08-28 Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression Karger, Annika Nandigama, Rajender Stenzinger, Albrecht Grimminger, Friedrich Pullamsetti, Soni Savai Seeger, Werner Savai, Rajkumar Cancers (Basel) Review SIMPLE SUMMARY: Cancer immunotherapy mainly targets immune system components, such as immune-suppressive networks generated by cancer cells in the tumor microenvironment (TME). Programmed cell death ligand 1, which is a secretory immune-suppressive factor, is released by tumor-associated macrophages (TAMs). The TME also disrupts production of tumor-specific T cells and generates immunosuppressive leukocytes, regulatory T cells, and myeloid-derived suppressor cells. Immune checkpoint inhibitors are effective in various cancers but only in a subset of patients. Non-coding RNAs, such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are dysregulated in cancer through transcriptional, post-transcriptional, and epigenetic changes and have significant roles in cancer initiation and progression, which depends on deregulation of lncRNA expression. TAM function can be influenced by lncRNAs in various ways. However, our understanding of lncRNA dysregulation and function in cancer remains in the early stage. ABSTRACT: Ever since RNA sequencing of whole genomes and transcriptomes became available, numerous RNA transcripts without having the classic function of encoding proteins have been discovered. Long non-coding RNAs (lncRNAs) with a length greater than 200 nucleotides were considered as “junk” in the beginning, but it has increasingly become clear that lncRNAs have crucial roles in regulating a variety of cellular mechanisms and are often deregulated in several diseases, such as cancer. Lung cancer is the leading cause of cancer-related deaths and has a survival rate of less than 10%. Immune cells infiltrating the tumor microenvironment (TME) have been shown to have a great effect on tumor development with macrophages being the major cell type within the TME. Macrophages can inherit an inflammatory M1 or an anti-inflammatory M2 phenotype. Tumor-associated macrophages, which are predominantly polarized to M2, favor tumor growth, angiogenesis, and metastasis. In this review, we aimed to describe the complex roles and functions of lncRNAs in macrophages and their influence on lung cancer development and progression through the TME. MDPI 2021-08-17 /pmc/articles/PMC8392679/ /pubmed/34439281 http://dx.doi.org/10.3390/cancers13164127 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Karger, Annika
Nandigama, Rajender
Stenzinger, Albrecht
Grimminger, Friedrich
Pullamsetti, Soni Savai
Seeger, Werner
Savai, Rajkumar
Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression
title Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression
title_full Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression
title_fullStr Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression
title_full_unstemmed Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression
title_short Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression
title_sort hidden treasures: macrophage long non-coding rnas in lung cancer progression
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392679/
https://www.ncbi.nlm.nih.gov/pubmed/34439281
http://dx.doi.org/10.3390/cancers13164127
work_keys_str_mv AT kargerannika hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression
AT nandigamarajender hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression
AT stenzingeralbrecht hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression
AT grimmingerfriedrich hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression
AT pullamsettisonisavai hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression
AT seegerwerner hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression
AT savairajkumar hiddentreasuresmacrophagelongnoncodingrnasinlungcancerprogression